Bilimsel Makale Arama | NeuralCipher AI

Açık erişim

Genetic variants in diseases of the extrapyramidal system.

Oczkowska A, Kozubski W, Lianeri M, Dorszewska J.

Curr Genomics · 2014-02-01

DOI: 10.2174/1389202914666131210213327PMID: 24653660

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

[Pathogenesis of Parkinson's disease through LRRK2 mutation].

Ohta E, Obata F.

Seikagaku · 2014-02-01

PMID: 24693706

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Transgenic mice expressing S129 phosphorylation mutations in α-synuclein.

Escobar VD, Kuo YM, Orrison BM, Giasson BI, Nussbaum RL.

Neurosci Lett · 2014-01-30

DOI: 10.1016/j.neulet.2014.01.033PMID: 24486885

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

A voxel-based morphometry and diffusion tensor imaging analysis of asymptomatic Parkinson's disease-related G2019S LRRK2 mutation carriers.

Thaler A, Artzi M, Mirelman A, Jacob Y, Helmich RC, van Nuenen BF, Gurevich T, Orr-Urtreger A, Marder K, Bressman S, Bloem BR, Hendler T, Giladi N, Ben Bashat D, LRRK2 Ashkenazi Jewish Consortium.

Mov Disord · 2014-01-30

DOI: 10.1002/mds.25827PMID: 24482120

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson's disease.

Murphy KE, Gysbers AM, Abbott SK, Tayebi N, Kim WS, Sidransky E, Cooper A, Garner B, Halliday GM.

Brain · 2014-01-28

DOI: 10.1093/brain/awt367PMID: 24477431

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Trifluoperazine rescues human dopaminergic cells from wild-type α-synuclein-induced toxicity.

Höllerhage M, Goebel JN, de Andrade A, Hildebrandt T, Dolga A, Culmsee C, Oertel WH, Hengerer B, Höglinger GU.

Neurobiol Aging · 2014-01-28

DOI: 10.1016/j.neurobiolaging.2014.01.027PMID: 24559643

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Recurrent and fatal akinetic crisis in genetic-mitochondrial parkinsonisms.

Bonanni L, Onofrj M, Valente EM, Manzoli L, De Angelis MV, Capasso M, Thomas A.

Eur J Neurol · 2014-01-28

DOI: 10.1111/ene.12364PMID: 24471704

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

[Epigenetic heredity (deoxyribonucleic acid methylation): Clinical context in neurodegenerative disorders and ATXN2 gene].

Laffita-Mesa JM, Bauer P.

Med Clin (Barc) · 2014-01-28

DOI: 10.1016/j.medcli.2013.11.025PMID: 24485162

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Pitx3 deficient mice as a genetic animal model of co-morbid depressive disorder and parkinsonism.

Kim KS, Kang YM, Kang Y, Park TS, Park HY, Kim YJ, Han BS, Kim CH, Lee CH, Ardayfio PA, Han PL, Jung BH, Kim KS.

Brain Res · 2014-01-27

DOI: 10.1016/j.brainres.2014.01.023PMID: 24480473

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Intranasal administration of alpha-synuclein aggregates: a Parkinson's disease model with behavioral and neurochemical correlates.

Gruden MA, Davydova TV, Narkevich VB, Fomina VG, Wang C, Kudrin VS, Morozova-Roche LA, Sewell RD.

Behav Brain Res · 2014-01-27

DOI: 10.1016/j.bbr.2014.01.017PMID: 24480422

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

LRRK2 regulates synaptogenesis and dopamine receptor activation through modulation of PKA activity.

Parisiadou L, Yu J, Sgobio C, Xie C, Liu G, Sun L, Gu XL, Lin X, Crowley NA, Lovinger DM, Cai H.

Nat Neurosci · 2014-01-26

DOI: 10.1038/nn.3636PMID: 24464040

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Genetics of Parkinson's disease: alpha-synuclein and other insights from Greece.

Proukakis C.

Eur J Neurol · 2014-01-25

DOI: 10.1111/ene.12357PMID: 24460978

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.

9.897 makale bulundu

Genetic variants in diseases of the extrapyramidal system.

[Pathogenesis of Parkinson's disease through LRRK2 mutation].

Transgenic mice expressing S129 phosphorylation mutations in α-synuclein.

A voxel-based morphometry and diffusion tensor imaging analysis of asymptomatic Parkinson's disease-related G2019S LRRK2 mutation carriers.

Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson's disease.

Trifluoperazine rescues human dopaminergic cells from wild-type α-synuclein-induced toxicity.

Recurrent and fatal akinetic crisis in genetic-mitochondrial parkinsonisms.

[Epigenetic heredity (deoxyribonucleic acid methylation): Clinical context in neurodegenerative disorders and ATXN2 gene].

Pitx3 deficient mice as a genetic animal model of co-morbid depressive disorder and parkinsonism.

Intranasal administration of alpha-synuclein aggregates: a Parkinson's disease model with behavioral and neurochemical correlates.

LRRK2 regulates synaptogenesis and dopamine receptor activation through modulation of PKA activity.

Genetics of Parkinson's disease: alpha-synuclein and other insights from Greece.

Filtreler